Newborn

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Related articles

VOLUME 1 , ISSUE 1 ( January-March, 2022 ) > List of Articles

REVIEW ARTICLE

Rotavirus Infection in Neonates and Young Infants

Preeti Shakya, Biplov Adhikari, Amit S Nepal, Pragyik Pandey, Akhil Maheshwari

Keywords : Diarrhea, Double-stranded ribonucleic acid, Gastroenteritis, Nonenveloped virus, Reovirus, Vaccine, World Health Organization

Citation Information : Shakya P, Adhikari B, Nepal AS, Pandey P, Maheshwari A. Rotavirus Infection in Neonates and Young Infants. 2022; 1 (1):142-150.

DOI: 10.5005/jp-journals-11002-0014

License: CC BY-NC 4.0

Published Online: 31-03-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Rotavirus is the primary cause of acute, frequently severe gastroenteritis among growing premature neonates, young infants, and children under the age of five globally. It contains a double-stranded ribonucleic acid genome is a member of the Reoviridae family. In this review, we have discussed the structure and characteristics of the virus, the pathogenesis of rotaviral diarrhea, clinical features, methods of diagnosis, clinical management, and available vaccines. This article combines peer-reviewed evidence from our own clinical studies with results of an extensive literature search in the databases PubMed, EMBASE, and Scopus.


HTML PDF Share
  1. Rotavirus infections in Western Pacific. 2021. Available from: https://www.who.int/westernpacific/health-topics/rotavirus-infections.
  2. Cicirello HG, Das BK, Gupta A, et al. High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus. Pediatr Infect Dis J 1994;13(8):720–723. DOI: 10.1097/00006454-199408000-00008.
  3. Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 2009;136(6):1939–1951. DOI: 10.1053/j.gastro.2009.02.076. Available from: http://www.gastrojournal.org/article/S0016508509003631/fulltext.
  4. Crawford SE, Ramani S, Tate JE, et al. Rotavirus infection. Nat Rev Dis Prim 2017;3:17083. PMCID: PMC5858916.
  5. Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev 2008;21(1):198–208. PMCID: PMC2223838.
  6. Rotavirus Classification Working Group: RCWG–Laboratory of Viral Metagenomics. 2021 Available from: https://rega.kuleuven.be/cev/viralmetagenomics/virus-classification/rcwg.
  7. WHO EMRO|Disease and epidemiology|Rotavirus gastroenteritis|Health topics. 2021. Available from: http://www.emro.who.int/health-topics/rotavirus-gastroenteritis/disease-and-epidemiology.html.
  8. Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis 2002;34:1351–1361. DOI: 10.1086/340103.
  9. Haffejee IE. Neonatal rotavirus infections. Clin Infect Dis 1991;13(5): 957–962. DOI: 10.1093/clinids/13.5.957.
  10. Grillner L, Broberger U, Chrystie I, et al. Rotavirus infections in newborns: an epidemiological and clinical study. Scand J Infect Dis 1985;17(4):349–355. PMID: 3003889.
  11. Totterdell BM, Chrystie IL, Banatvala IE. Rotavirus infections in a maternity unit. Arch Dis Child 1976;51(12):924–928. DOI: 10.1136/adc.51.12.924.
  12. Bishop RF, Hewstone AS, Davidson GP, et al. An epidemic of diarrhoea in human neonates involving a reovirus-like agent and “enteropathogenic” serotypes of Escherichia coli. 1 Clin Pathol 1976;29(1):46–49. DOI: 10.1136/jcp.29.1.46.
  13. Murphy AM, Albrey MB, Hay P. Rotavirus infections in neonates [letter]. Lancet 1975;2(7932):452–453. DOI: 10.1016/s0140-6736 (75)90859-4.
  14. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9(5):565–572. PMCID: PMC2972763.
  15. Pereira P, Vetter V, Standaert B, et al. Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned. Expert Rev Vaccines 2020;19(8):755–769. DOI: 10.1080/14760584.2020.1800459. Available from: https://www.tandfonline.com/action/journalInformation?journalCode=ierv20.
  16. Ali Z, Harastani H, Hammadi M, et al. Rotavirus genotypes and vaccine effectiveness from a sentinel, hospital-based, surveillance study for three consecutive rotavirus seasons in Lebanon. PLoS One 2016;11(8):e0161345. DOI: 10.1371/journal.pone.0161345. Available from: http://www.iucnredlist.org.
  17. WHO Diarrhoel Diseases. WHO. Available at: https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease.
  18. Center for Disease Control and Prevention (CDC). Rotavirus. Pink B. 2014. p. 263–274. Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/rota.pdf.
  19. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol 2004;78(19):10213–10220. DOI: 10.1128/JVI.78.19.10213-10220.2004. Available from: https://journals.asm.org/journal/jvi.
  20. Osborne MP, Haddon SJ, Spencer AJ, et al. An electron microscopic investigation of time-related changes in the intestine of neonatal mice infected with murine rotavirus. J Pediatr Gastroenterol Nutr 1988;7(2):236–248. PMID: 2832583.
  21. Bernstein DI. Rotavirus overview. Pediatr Infect Dis J 2009;28(Suppl. 3): S50-S53. PMID: 19252423.
  22. Ramani S, Sowmyanarayanan TV, Gladstone BP, et al. Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India. Pediatr Infect Dis J 2008;27(8):719–723. PMID: 18600189.
  23. Kang G. Viral diarrhea. In: International encyclopedia of public health. Elsevier Inc.; 2016. p. 360–367. PMID: 29262044.
  24. Shim JO, Son DW, Shim SY, et al. Clinical characteristics and genotypes of rotaviruses in a neonatal intensive care unit. Pediatr Neonatol 2012;53(1):18–23. DOI: 10.1016/j.pedneo.2011.11.005. Available from: https://koreauniv.pure.elsevier.com/en/publications/clinical-characteristics-and-genotypes-of-rotaviruses-in-a-neonat.
  25. Hoxha T, Xhelili L, Azemi M, et al. Performance of clinical signs in the diagnosis of dehydration in children with acute gastroenteritis. Med Arch (Sarajevo, Bosnia Herzegovina) 2015;69(1):10–12. PMCID: PMC4384849.
  26. Slifka MK, Amanna IJ. Passive immunization. In: Plotkin's vaccines. Elsevier; 2018. p. 84–95.e10. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323357616000080.
  27. Linhares AC, Melo VR, D'Arc Mascarenhas Gabbay PJYB, et al. Pattern of acquisition of rotavirus antibody in children followed up from birth to the age of three years. Rev Soc Bras Med Trop 1989;22(1):25–29. DOI: 10.1590/s0037-86821989000100005.
  28. Cameron DIS, Bishop RF, Veenstra AA, et al. Non-cultivable viruses and neonatal diarrhea: fifteen-month survey in a newborn special care nursery. Clin Microbiol 1978;8(1):93–98. DOI: 10.1128/jcm.8.1.93-98.1978.
  29. Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect Dis 2004;4(2):91–99. PMCID: PMC7106507.
  30. Parashar UD, Nelson EAS, Kang G. Diagnosis, management, and prevention of rotavirus gastroenteritis in children. BMJ 2013;347:f7204. PMCID: PMC5776699.
  31. Rodák L, Šmíd B, Nevoránková Z, et al. Verification of sensitivity and specificity of group A rotavirus detection in piglets faeces with monoclonal blocking ELISA methods. J Vet Med Ser B Infect Dis Vet Public Heal 2004;51(4):160–165. PMCID: PMC7165794.
  32. Thomas EE, Puterman ML, Kawano E, et al. Evaluation of seven immunoassays for detection of rotavirus in pediatric stool samples. J Clin Microbiol 1988;26(6):1189–1193. PMCID: PMC266559.
  33. Stuempfig ND, Seroy J. Viral gastroenteritis. StatPearls; 2021. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30085537.
  34. Guerrant RL, Van Gilder T, Slutsker L, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331–351. PMID: 11170940.
  35. International Study Group on Reduced-osmolarity ORS Solutions, et al. Multicentre evaluation of reduced-osmolarity oral rehydration salts solution. Lancet 1995;345(8945):282–285. PMID: 7837862.
  36. Bhutta ZA. Acute gastroenteritis in children. In: Kliegman R, Behrman R, Jenson H, Stanton B, editors. In: Nelson textbook of pediatrics. 18th ed. Saundres; 2008. p. 1614.
  37. Bhan MK, Mahalanabis D, Fontaine O, et al. Clinical trials of improved oral rehydration salt formulations: a review. Bull World Health Organ 1994;72(6):945–955. PMID: 7867142.
  38. Guiraldes E, Trivino X, Hodgson MI, et al. Treatment of acute infantile diarrhoea with a commercial rice-based oral rehydration solution. J Diarrhoeal Dis Res 1995;13(4):207–211. PMID: 8838821.
  39. Santosham M, Glass RI. The management of acute diarrhea in children: oral rehydration maintenance and nutritional therapy. MMWR Morb Mortal Wkly Rep 1992;41:1–20. PMID: 1435668.
  40. Kartha GB, Rameshkumar R, Mahadevan S. Randomized Double-blind Trial of Ringer Lactate Versus Normal Saline in Pediatric Acute Severe Diarrheal Dehydration. J Pediatr Gastroenterol Nutr 2017 65(6): 621–626. DOI: 10.1097/MPG.0000000000001609.
  41. Santosham M, Burns BA, Reid R, et al. Glycin-based oral rehydration solution: reassessment of safety and efficacy. J Pediatr 1986;109(5): 795–801. DOI: 10.1016/s0022-3476(86)80696-5.
  42. Shornikova AV, Isolauri E, Burkanova L, et al. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 1997;86(5):460–465. DOI: 10.1111/j.1651-2227.1997.tb08913.x.
  43. Uhnoo IS, Freihorst J, Riepenhoff TM, et al. Effect of rotavirus infection and malnutrition on uptake of a dietary antigen in the intestine. Pediatr Res 1990;27(2):153–160. DOI: 10.1203/00006450-199002000-00014.
  44. Bhal R, Bhandari N, Hambidge KM, et al. Plasma zinc as a predictor of diarrheal and respiratory morbidity in children in an urban slum setting. Am J Clin Nutr 1998;68(2 Suppl.):414–417. DOI: 10.1093/ajcn/68.2.414S.
  45. Bhatangar S, Bhandari N, Mouli UC, et al. Consensus statement of IAP National Task Force: status report on management of acute diarrhea. Indian Pediatr 2004;41(4):335–348. PMID: 15123862.
  46. Black RE. Zinc deficiency, infectious diseases and mortality in the developing world. J Nut 2003;133(5 Suppl 1):1485S–1489S. DOI: 10.1093/jn/133.5.1485S.
  47. Zinc Investigators’ Collaborative Group. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 2000;72(6):1516–1522. DOI: 10.1093/ajcn/72.6.1516.
  48. Ghana VAST Study Team. Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Lancet 1993;342(8862):7–12 [erratum: Lancet 1993;342(8865):250]. PMID: 8100345.
  49. Rahmathullah L, Underwood BA, Thulasiraj RD, et al. Reduced mortality among children in southern India receiving a small weekly dose of vitamin A. N Engl J Med 1990;323(14):929–935. DOI: 10.1056/NEJM199010043231401.
  50. Daulaire NM, Starbuck ES, Houston RM, et al. Childhood mortality after a high dose of vitamin A in a high risk population. BMJ 1992;304(6821):207–210. DOI: 10.1136/bmj.304.6821.207.
  51. Guarino A, Canani RB, Russo S, et al. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics 1994;93(1): 12–16. PMID: 8265305.
  52. Overview|Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management|Guidance|NICE.
  53. Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update. J Pediatr Gastroenterol Nutr 2014;59(1):132–152. PMID: 24739189.
  54. Freedman SB, Pasichnyk D, Black KJ, et al. Gastroenteritis therapies in developed countries: systematic review and meta-analysis. PLoS One 2015;10(6):e0128754. DOI: 10.1371/journal.pone.0128754.
  55. Introduction of rotavirus vaccines. Information for Policy Makers, Programme Managers, and Health Workers. 2013.
  56. John B, Devgan A, Mitra B. Prevalence of rotavirus infection in children below two years presenting with diarrhea. Med J Armed Forces India 2014;70(2):116–119. DOI: 10.1016/j.mjafi.2014.02.008.
  57. Kurugöl Z, Geylani S, Karaca Y, et al. Rotavirus gastroenteritis among children under five years of age in Izmir, Turkey. Turk J Pediatr 2003;45(4):290–294. PMID: 14768791.
  58. Linhares AC, Gabbay YB, Freitas RB, et al. Longitudinal study of rotavirus infections among children from Belém, Brazil. Epidemiol Infect 1989;102(1):129. DOI: 10.1017/s0950268800029769.
  59. Shen J, Zhang B-M, Zhu S-G, et al. No direct correlation between rotavirus diarrhea and breast feeding: a meta-analysis. Pediatr Neonatol 2018;59(2):129–135. DOI: 10.1016/j.pedneo. 2017.06.002. Available from: http://creativecommons.org/licenses/by-nc-nd/4.0/.
  60. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators Collaborative Group. J Pediatr 1999;135(6):689–697. DOI: 10.1016/s0022-3476(99)70086-7.
  61. Aiello AE, Larson EL. What is the evidence for a causal link between hygiene and infections? Lancet Infect Dis 2002;2(2):103–110. DOI: 10.1016/s1473-3099(02)00184-6.
  62. Parashar UD, Alexander JP, Glass RI Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2006;55(RR-12):1–13. PMID: 16902398.
  63. Staat MA, Payne DC, Halasa N, et al. Continued evidence of the impact of rotavirus vaccine in children less than 3 years of age from the United States new vaccine surveillance network: a multisite active surveillance program, 2006–2016. Clin Infect Dis 2020;71(9): E421–E429. DOI: 10.1093/cid/ciaa150.
  64. Martinez-Gutierrez M, Hernandez-Mira E, Rendon-Marin S, et al. Wa-1 equine-like G3P[8] rotavirus from a child with diarrhea in Colombia. Viruses 2021;13(6):1075. DOI: 10.3390/v13061075. Available from: https://www.mdpi.com/1999-4915/13/6/1075.
  65. Troeger C, Khalil IA, Rao PC, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr 2018;172(10):958–965. DOI: 10.1001/jamapediatrics.2018.1960. Available from: https://jamanetwork.com/.
  66. International Vaccine Access Center (IVAC). Johns Hopkins Bloomberg School of Public Health. Available at: www.view-hub.org [Accessed March 14, 2019].
  67. Podewils LJ, Antil L, Hummelman E, et al. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005;192(Suppl. 1):S133–S145. PMID: 16088797.
  68. Haffejee IE. Neonatal rotavirus infections. Rev Infect Dis 1991;13(5): 957–962. PMID: 1660185.
  69. Omenaca F, Sarlangue J, Szenborn L, et al. ROTA-054 Study Group. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study. Pediatr Infect Dis J 2012;31(5):487–93. DOI: 10.1097/INF.0b013e3182490a2c.
  70. Huppertz H-I, Salman N, Giaquinto C. Risk factors for severe rotavirus gastroenteritis. Pediatr Infect Dis J 2008;27(1):S11–S19. DOI: 10.1097/INF.0b013e31815eee0a.
  71. Sharma R, Hudak ML, Premachandra BR, et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J 2002;21(12):1099–1105. DOI: 10.1097/00006454-200212000-00003.
  72. De Villiers FPR, Steele AD, Driessen M. Cental nervous system involvement in neonatal rotavirus infection. Ann Trop Paediatr 2003;23(4):309–312. DOI: 10.1179/027249303225007789.
  73. Waggie Z, Hawkridge A, Hussey GD. Review of rotavirus studies in Africa: 1976–2006. J Infect Dis 2010;202:S23–S33. DOI: 10.1086/653554.
  74. Hwang NR, Kim JK. Relationship between asymptomatic rotavirus infection and jaundice in neonates: a retrospective study. BMC Pediatr 2018;18(1):1–6. DOI: 10.1186/s12887-018-1352-z.
  75. Ramani S, Sowmyanarayanan TV, Primrose Gladstone B, et al. Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India. Pediatr Infect Dis J 2008;27(8):719–723. DOI: 10.1097/INF.0b013e3181715170.
  76. Johansen K, Hedlund K-O, Zweygberg-Wirgart B, et al. Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance. Scand J Infect Dis 2008;40(11–12):958–964. DOI: 10.1080/00365540802415509.
  77. Lowenthal A, Livni G, Amir J, et al. Secondary bacteremia after rotavirus gastroenteritis in infancy. Pediatrics 2006;117(1):224–226. DOI: 10.1542/peds.2005-0177.
  78. Rotbart HA, Levin MJ, Yolken RH, et al. An outbreak of rotavirus associated with neonatal necrotizing enterocolitis. J Pediatr 1983;103(3):454–459. DOI: 10.1016/s0022-3476(83)80427-2.
  79. Lee EH, Chung S. A comparative study of febrile and afebrile seizures associated with mild gastroenteritis. Brain Dev 2013;35(7):636–640. PMID: 23111347.
  80. Caraballo RH, Gañez L, Santos CD, et al. Benign infantile seizures with mild gastroenteritis: study of 22 patients. Seizure 2009;18(10): 686–689. PMID: 19828335.
  81. Thompson MJ, Gowdie PJ, Kirkwood CD, et al. Rotavirus cerebellitis: new aspects to an old foe? Pediatr Neurol 2012;46(1):48–50. PMID: 22196493.
  82. Matsuno S, Utagawa E, Sugiura A. Association of rotavirus infection with Kawasaki syndrome. J Infect Dis 1983;148(1):177–177. PMID: 6309994.
  83. Tillotson JR, Lerner AM. Reovirus type 3 associated with fatal pneumonia. N Engl J Med 1967;276(19):1060–1063. PMID: 6025662.
  84. Joske RA, Keall DD, Leak PJ, et al. Hepatitis-encephalitis in humans with reovirus infection. Arch Intern Med 1964;113(6): 811–816. DOI: 10.1001/archinte.1964.00280120011003. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/570176.
  85. El-Rai FM, Evans AS. Reovirus infections in children and young adults. Arch Environ Health 1963;7(6):700–704. PMID: 14077218.
  86. Yolkend R, Murphy M. Sudden infant death syndrome associated with rotavirus infection. J Med Virol 1982;10(4):291–296. DOI: 10.1002/jmv.1890100409. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.1890100409.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.